(Q37871345)

24 August 2017

1 reference

title

Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease (English)

1 reference

gastroesophageal reflux disease

24 August 2017

main subject

0 references

author name string

Peter J Kahrilas

series ordinal

1

1 reference

24 August 2017

Colin W Howden

series ordinal

2

1 reference

24 August 2017

Nesta Hughes

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

3 May 2011

1 reference

The American Journal of Gastroenterology

24 August 2017

published in

1 reference

24 August 2017

volume

106

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

1419-25; quiz 1426

1 reference

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Management of symptoms in step-down therapy of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Symptom-relieving Effect of Esomeprazole 40 mg Daily in Patients with Heartburn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

When proton pump inhibitors fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.146

Medical treatments in the short term management of reflux oesophagitis

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003244.PUB2

Identifiers

DOI

10.1038/AJG.2011.146

1 reference

24 August 2017

1 reference